Skip to content
Medical Health Aged Care

CLP election proposal risks the health of Territorians

Royal Australian College of GPs 2 mins read

The Country Liberal Party’s proposal allowing pharmacists to treat 21 conditions if elected risks the health of Territorians, including misdiagnosis and incorrect treatment, warns the Royal Australian College of GPs (RACGP). 

The RACGP has written to the CLP to warn against the proposal, which would allow pharmacists to provide drugs for 21 conditions without a GP diagnosing and prescribing them to a patient. This contravenes Therapeutic Goods Administration (TGA) rules for medicines designed to protect the health of Australians. 

RACGP Northern Territory Chair Dr Sam Heard said GPs in the Northern Territory are extremely concerned. 

“The Country Liberals haven't consulted GPs in the Northern Territory, and we are extremely concerned that there has been no consideration given to the potential risks to peoples’ health – including incorrect and missed diagnosis, and incorrect treatment,” he said.  

“Patients don’t present with a diagnosis, they just have symptoms, which might be any number of conditions. For example, the symptoms of a UTI are similar to symptoms for pregnancy, STIs, cancer and undiagnosed diabetes. 

Diagnosing a patient is difficult, which is why GPs train for over 10 years. Pharmacists play an important role in dispensing and giving advice on medicines but they are not trained to diagnose patients.  

The risks associated with this approach were seen in Queensland, where a survey of more than 1,300 doctors found more than 240 cases of misdiagnosis associated with the North Queensland UTI Pharmacy Prescribing Trial. At least nine patients needed hospitalisation relating to ineffective or delayed medical treatment.  

“Were especially concerned by the number of conditions in the list requiring treatment with antibiotics. Inappropriate prescribing of antibiotics increases the risk of antibiotic resistance in the community. When this happens, simple infections can become life threatening. This is not something we can risk in the Northern Territory. The broader scope of practice for nurses and Aboriginal health practitioners that we have in the NT is already resulting in antibiotic resistance. Over the counter supply of antibiotics will make it much worse.  

Making prescription medicines easier to access should not be prioritised over access to high quality general practice care for NT patients and families. The RACGP is keen to discuss real solutions to improve access to GPs in the Northern Territory with the Country Liberals. 

“The RACGP encourages the next Territory government to focus on improving access to high quality general practice care for Territorians and ensuring the sustainability of general practice. Territorians deserve high quality primary healthcare that they can trust, not bandaid solutions that risk peoples health.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:
  • Government VIC, Medical Health Aged Care
  • 08/12/2025
  • 07:53
Public Health Association of Australia

Five VicHealth former chairs urge government retain the health promotion foundation

Open letter to the Victorian Premier, Treasurer, and Health Minister (Issued by the Public Health Association of Australia on the authors' behalf). 8 December 2025 As five former Chairs ofVicHealth, representing a broad political spectrum and different eras of VicHealth’s work, we write to ask you to reconsider your Government’s decision to abolish VicHealth and place its important preventative health functions in the Health Department.We believe the decision is misguided and will fail to deliver the hoped-for savings. Abolishing VicHealth will severely reduce the effectiveness of important and innovative public health work in this State. Even with the best intentions,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.